Werewolf Therapeutics, Inc. (HOWL)

Form 4 sales, Form 144 notices and lockup dates

Sales chart range
Log in to watch HOWL
Latest sale
$45k
Jul 7 · Routine
Form 4 sales
57
On record
Form 144 notices
0
Proposed sales
Next unlock
None
No lockup ahead

Lockups

No lockup on record.

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Timeline

  1. 1 Form 4 saleRoutine
    Jun 3 2026

    Sold 139,803 shares at $0.46 ($64k)

    Evnin Luke, Director

    10b5-1 planSold 22.5% of holdings ($283k position)482,776 shares left1.1x usual sizeFiling

  2. 2 Form 4 saleRoutine
    Jun 8 +5 days

    Sold 105,565 shares at $0.41 ($43k)

    Evnin Luke, Director

    10b5-1 planSold 21.9% of holdings ($197k position)377,211 shares left0.8x usual sizeFiling

  3. 3 Form 4 saleRoutine
    Jun 9 +1 day

    Sold 76,928 shares at $0.37 ($28k)

    Evnin Luke, Director

    10b5-1 planSold 20.4% of holdings ($140k position)300,283 shares left0.6x usual sizeFiling

  4. 4 Form 4 saleUnusual
    Jun 11 +2 days

    Sold 678,226 shares at $0.37 ($254k)

    Kolchinsky Peter, 10% owner

    No 10b5-1 planSold 65.2% of holdings ($389k position)361,229 shares leftFirst sale on recordFiling

  5. 5 Form 4 saleUnusual
    Jun 16 +5 days

    Sold 448,836 shares at $0.39 ($174k)

    Ra Capital Management, L.P., 10% owner

    No 10b5-1 planSold 57.5% of holdings ($302k position)331,414 shares leftFiling

  6. 6 Form 4 saleUnusual
    Jun 17 +1 day

    Sold 416,911 shares at $0.35 ($146k)

    Ra Capital Management, L.P., 10% owner

    No 10b5-1 planSold 57.9% of holdings ($252k position)303,719 shares leftFiling

  7. 7 Form 4 saleRoutine
    Jun 29 +12 days

    Sold 157,084 shares at $0.30 ($47k)

    Evnin Luke, Director

    10b5-1 planSold 52.3% of holdings ($90k position)143,199 shares left1.3x usual sizeFiling

  8. 8 Form 4 saleRoutine
    Jul 7 +8 days

    Sold 143,199 shares at $0.31 ($45k)

    Evnin Luke, Director

    10b5-1 planSold 100% of holdings ($45k position)0 shares left1.1x usual sizeFiling

Every transaction

Loading transactions…

Sales, notices and lockups (57)

Export watchlist as CSV
Lockups, Form 144 notices and Form 4 sales for HOWL
Source
Jul 7, 2026Evnin LukeDirectorForm 4 sale143,199$45k100.0%RoutineSEC
Jun 29, 2026Evnin LukeDirectorForm 4 sale157,084$47k52.3%RoutineSEC
Jun 17, 2026Ra Capital Management, L.P.10% ownerForm 4 sale416,911$146k57.9%UnusualSEC
Jun 16, 2026Ra Capital Management, L.P.10% ownerForm 4 sale448,836$174k57.5%UnusualSEC
Jun 11, 2026Kolchinsky Peter10% ownerForm 4 sale678,226$254k65.2%UnusualSEC
Jun 9, 2026Evnin LukeDirectorForm 4 sale76,928$28k20.4%RoutineSEC
Jun 8, 2026Evnin LukeDirectorForm 4 sale105,565$43k21.9%RoutineSEC
Jun 3, 2026Evnin LukeDirectorForm 4 sale139,803$64k22.5%RoutineSEC
May 29, 2026Evnin LukeDirectorForm 4 sale141,106$66k18.5%RoutineSEC
May 26, 2026Evnin LukeDirectorForm 4 sale191,762$87k20.1%RoutineSEC
May 20, 2026Evnin LukeDirectorForm 4 sale171,049$76k15.2%RoutineSEC
May 13, 2026Evnin LukeDirectorForm 4 sale44,679$24k3.8%RoutineSEC
May 12, 2026Ra Capital Management, L.P.10% ownerForm 4 sale565,167$391k58.2%UnusualSEC
May 12, 2026Evnin LukeDirectorForm 4 sale407,574$280k25.8%UnusualSEC
May 7, 2026Evnin LukeDirectorForm 4 sale100,581$64k6.0%RoutineSEC
May 4, 2026Evnin LukeDirectorForm 4 sale274,619$198k14.1%RoutineSEC
Apr 29, 2026Evnin LukeDirectorForm 4 sale205,911$155k9.5%RoutineSEC
Jan 16, 2026Evnin LukeDirectorForm 4 sale38,782$21k1.8%RoutineSEC
Jan 15, 2026Evnin LukeDirectorForm 4 sale111,227$62k4.8%RoutineSEC
Jan 12, 2026Evnin LukeDirectorForm 4 sale91,374$54k3.8%RoutineSEC
Jan 7, 2026Evnin LukeDirectorForm 4 sale71,054$46k2.9%RoutineSEC
Jan 2, 2026Evnin LukeDirectorForm 4 sale78,377$48k3.1%RoutineSEC
Dec 29, 2025Evnin LukeDirectorForm 4 sale291,283$185k10.2%RoutineSEC
Dec 17, 2025Evnin LukeDirectorForm 4 sale48,171$52k1.7%RoutineSEC
Dec 12, 2025Evnin LukeDirectorForm 4 sale82,971$89k2.8%RoutineSEC
Dec 9, 2025Evnin LukeDirectorForm 4 sale95,179$95k3.1%RoutineSEC
Dec 4, 2025MPM BioVentures 2014 (B), L.P.OtherForm 4 sale199,732$183k4.0%RoutineSEC
Dec 4, 2025MPM BioImpact LLCOtherForm 4 sale199,732$183k4.0%RoutineSEC
Dec 4, 2025Evnin LukeDirectorForm 4 sale128,185$118k4.0%RoutineSEC
Dec 1, 2025MPM Asset Management Investors BV2014 LLC10% ownerForm 4 sale141,927$137k2.8%RoutineSEC
Dec 1, 2025UBS Oncology Impact Fund L.P.10% ownerForm 4 sale141,927$137k2.8%RoutineSEC
Dec 1, 2025Evnin LukeDirectorForm 4 sale91,088$88k2.8%RoutineSEC
Nov 25, 2025MPM BioVentures 2014 GP LLC10% ownerForm 4 sale195,666$180k3.7%RoutineSEC
Nov 25, 2025MPM Oncology Innovations Fund GP LLC10% ownerForm 4 sale195,666$180k3.7%RoutineSEC
Nov 25, 2025Evnin LukeDirectorForm 4 sale125,576$115k3.7%RoutineSEC
Nov 20, 2025MPM BioVentures 2014 LLC10% ownerForm 4 sale160,103$148k2.9%RoutineSEC
Nov 20, 2025MPM Oncology Innovations Fund GP LLC10% ownerForm 4 sale160,103$148k2.9%RoutineSEC
Nov 20, 2025Evnin LukeDirectorForm 4 sale102,753$95k2.9%RoutineSEC
Nov 17, 2025MPM BioVentures 2014 LLC10% ownerForm 4 sale209,652$201k3.7%RoutineSEC
Nov 17, 2025MPM Oncology Innovations Fund GP LLC10% ownerForm 4 sale209,652$201k3.7%RoutineSEC
Nov 17, 2025Evnin LukeDirectorForm 4 sale134,553$129k3.7%RoutineSEC
Nov 12, 2025MPM BioVentures 2014, L.P.10% ownerForm 4 sale213,529$241k3.6%RoutineSEC
Nov 12, 2025UBS Oncology Impact Fund L.P.10% ownerForm 4 sale213,529$241k3.6%RoutineSEC
Nov 12, 2025Evnin LukeDirectorForm 4 sale137,041$155k3.6%RoutineSEC
Nov 6, 2025MPM BioVentures 2014 LLC10% ownerForm 4 sale242,890$296k4.0%RoutineSEC
Nov 6, 2025MPM BioImpact LLC10% ownerForm 4 sale242,890$296k4.0%RoutineSEC
Nov 6, 2025Evnin LukeDirectorForm 4 sale155,885$190k4.0%RoutineSEC
Nov 3, 2025MPM Asset Management Investors BV2014 LLC10% ownerForm 4 sale295,043$392k4.6%RoutineSEC
Nov 3, 2025Mpm Oncology Innovations Fund LP10% ownerForm 4 sale295,043$392k4.6%RoutineSEC
Nov 3, 2025Evnin LukeDirectorForm 4 sale189,356$251k4.6%RoutineSEC
Oct 29, 2025Evnin LukeDirectorForm 4 sale177,145$286k4.1%RoutineSEC
Oct 29, 2025MPM BioVentures 2014 LLC10% ownerForm 4 sale276,017$446k4.1%RoutineSEC
Oct 29, 2025UBS Oncology Impact Fund L.P.10% ownerForm 4 sale276,017$446k4.1%RoutineSEC
Mar 27, 2025MPM Asset Management Investors BV2014 LLC10% ownerForm 4 sale1,963$2k0.1%No planSEC
Mar 27, 2025Evnin LukeDirector, 10% ownerForm 4 sale2,425$3k0.1%No planSEC
Mar 27, 2025Mpm Asset Management LLC10% ownerForm 4 sale4,386$5k0.1%No planSEC
Dec 15, 2021Leonard ReidChief Operating OfficerForm 4 sale3,000$40k2.4%Plan not statedSEC